Shares of Johnson Matthey PLC (LON:JMAT – Get Free Report) have been given an average rating of “Moderate Buy” by the six analysts that are currently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is GBX 2,283.33.
Several research firms have commented on JMAT. UBS Group reaffirmed a “neutral” rating and issued a GBX 2,200 target price on shares of Johnson Matthey in a research note on Friday, May 22nd. Jefferies Financial Group reissued a “buy” rating and set a GBX 2,330 price target on shares of Johnson Matthey in a research note on Tuesday. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 2,400 price objective on shares of Johnson Matthey in a report on Monday, July 6th. Finally, Berenberg Bank lifted their price objective on Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the company a “buy” rating in a research report on Monday, June 1st.
Check Out Our Latest Analysis on Johnson Matthey
Johnson Matthey Stock Performance
Johnson Matthey (LON:JMAT – Get Free Report) last posted its quarterly earnings data on Thursday, May 28th. The company reported GBX 128.50 earnings per share for the quarter. The business had revenue of GBX 1,257.30 billion during the quarter. Johnson Matthey had a negative net margin of 0.76% and a negative return on equity of 4.66%. On average, equities analysts anticipate that Johnson Matthey will post 173.4112903 earnings per share for the current year.
Insiders Place Their Bets
In related news, insider Alastair Judge acquired 14 shares of the business’s stock in a transaction dated Wednesday, June 10th. The shares were acquired at an average cost of GBX 1,990 per share, for a total transaction of £278.60. Also, insider Andrew Cosslett acquired 6,884 shares of the business’s stock in a transaction dated Wednesday, June 3rd. The shares were bought at an average price of GBX 2,168 per share, for a total transaction of £149,245.12. Insiders bought a total of 11,482 shares of company stock valued at $24,691,314 in the last quarter. Corporate insiders own 0.58% of the company’s stock.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Featured Articles
- Five stocks we like better than Johnson Matthey
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
